Literature DB >> 36131018

A cellular hierarchy in melanoma uncouples growth and metastasis.

Ignacio Bordeu1,2,3, Joanna Pozniak4,5, Ada Nowosad4,5, Panagiotis Karras4,5, Cecilia Pazzi4,5, Nina Van Raemdonck4,5, Ewout Landeloos4,5, Yannick Van Herck6, Dennis Pedri4,5, Greet Bervoets4,5, Samira Makhzami4,5, Jia Hui Khoo7, Benjamin Pavie8,9,10, Jochen Lamote11, Oskar Marin-Bejar4,5, Michael Dewaele4,5, Han Liang7, Xingju Zhang7, Yichao Hua5,12, Jasper Wouters13,14, Robin Browaeys15,16, Gabriele Bergers5,12, Yvan Saeys15,16, Francesca Bosisio17, Joost van den Oord17, Diether Lambrechts18,19, Anil K Rustgi20, Oliver Bechter6, Cedric Blanpain21, Benjamin D Simons1,2,22, Florian Rambow23,24,25,26,27, Jean-Christophe Marine28,29.   

Abstract

Although melanoma is notorious for its high degree of heterogeneity and plasticity1,2, the origin and magnitude of cell-state diversity remains poorly understood. Equally, it is unclear whether growth and metastatic dissemination are supported by overlapping or distinct melanoma subpopulations. Here, by combining mouse genetics, single-cell and spatial transcriptomics, lineage tracing and quantitative modelling, we provide evidence of a hierarchical model of tumour growth that mirrors the cellular and molecular logic underlying the cell-fate specification and differentiation of the embryonic neural crest. We show that tumorigenic competence is associated with a spatially localized perivascular niche, a phenotype acquired through an intercellular communication pathway established by endothelial cells. Consistent with a model in which only a fraction of cells are fated to fuel growth, temporal single-cell tracing of a population of melanoma cells with a mesenchymal-like state revealed that these cells do not contribute to primary tumour growth but, instead, constitute a pool of metastatic initiating cells that switch cell identity while disseminating to secondary organs. Our data provide a spatially and temporally resolved map of the diversity and trajectories of melanoma cell states and suggest that the ability to support growth and metastasis are limited to distinct pools of cells. The observation that these phenotypic competencies can be dynamically acquired after exposure to specific niche signals warrant the development of therapeutic strategies that interfere with the cancer cell reprogramming activity of such microenvironmental cues.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 36131018     DOI: 10.1038/s41586-022-05242-7

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


  48 in total

1.  Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.

Authors:  Itay Tirosh; Benjamin Izar; Sanjay M Prakadan; Marc H Wadsworth; Daniel Treacy; John J Trombetta; Asaf Rotem; Christopher Rodman; Christine Lian; George Murphy; Mohammad Fallahi-Sichani; Ken Dutton-Regester; Jia-Ren Lin; Ofir Cohen; Parin Shah; Diana Lu; Alex S Genshaft; Travis K Hughes; Carly G K Ziegler; Samuel W Kazer; Aleth Gaillard; Kellie E Kolb; Alexandra-Chloé Villani; Cory M Johannessen; Aleksandr Y Andreev; Eliezer M Van Allen; Monica Bertagnolli; Peter K Sorger; Ryan J Sullivan; Keith T Flaherty; Dennie T Frederick; Judit Jané-Valbuena; Charles H Yoon; Orit Rozenblatt-Rosen; Alex K Shalek; Aviv Regev; Levi A Garraway
Journal:  Science       Date:  2016-04-08       Impact factor: 47.728

2.  Role of the INK4a locus in tumor suppression and cell mortality.

Authors:  M Serrano; H Lee; L Chin; C Cordon-Cardo; D Beach; R A DePinho
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

3.  Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background.

Authors:  Julien Ackermann; Manon Frutschi; Kostas Kaloulis; Thomas McKee; Andreas Trumpp; Friedrich Beermann
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

4.  Single-cell transcriptional diversity is a hallmark of developmental potential.

Authors:  Gunsagar S Gulati; Shaheen S Sikandar; Daniel J Wesche; Anoop Manjunath; Anjan Bharadwaj; Mark J Berger; Francisco Ilagan; Angera H Kuo; Robert W Hsieh; Shang Cai; Maider Zabala; Ferenc A Scheeren; Neethan A Lobo; Dalong Qian; Feiqiao B Yu; Frederick M Dirbas; Michael F Clarke; Aaron M Newman
Journal:  Science       Date:  2020-01-24       Impact factor: 47.728

5.  Toward Minimal Residual Disease-Directed Therapy in Melanoma.

Authors:  Florian Rambow; Aljosja Rogiers; Oskar Marin-Bejar; Sara Aibar; Julia Femel; Michael Dewaele; Panagiotis Karras; Daniel Brown; Young Hwan Chang; Maria Debiec-Rychter; Carmen Adriaens; Enrico Radaelli; Pascal Wolter; Oliver Bechter; Reinhard Dummer; Mitchell Levesque; Adriano Piris; Dennie T Frederick; Genevieve Boland; Keith T Flaherty; Joost van den Oord; Thierry Voet; Stein Aerts; Amanda W Lund; Jean-Christophe Marine
Journal:  Cell       Date:  2018-07-12       Impact factor: 41.582

6.  A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.

Authors:  Livnat Jerby-Arnon; Parin Shah; Michael S Cuoco; Christopher Rodman; Mei-Ju Su; Johannes C Melms; Rachel Leeson; Abhay Kanodia; Shaolin Mei; Jia-Ren Lin; Shu Wang; Bokang Rabasha; David Liu; Gao Zhang; Claire Margolais; Orr Ashenberg; Patrick A Ott; Elizabeth I Buchbinder; Rizwan Haq; F Stephen Hodi; Genevieve M Boland; Ryan J Sullivan; Dennie T Frederick; Benchun Miao; Tabea Moll; Keith T Flaherty; Meenhard Herlyn; Russell W Jenkins; Rohit Thummalapalli; Monika S Kowalczyk; Israel Cañadas; Bastian Schilling; Adam N R Cartwright; Adrienne M Luoma; Shruti Malu; Patrick Hwu; Chantale Bernatchez; Marie-Andrée Forget; David A Barbie; Alex K Shalek; Itay Tirosh; Peter K Sorger; Kai Wucherpfennig; Eliezer M Van Allen; Dirk Schadendorf; Bruce E Johnson; Asaf Rotem; Orit Rozenblatt-Rosen; Levi A Garraway; Charles H Yoon; Benjamin Izar; Aviv Regev
Journal:  Cell       Date:  2018-11-01       Impact factor: 41.582

7.  New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis.

Authors:  Florian Rambow; Bastien Job; Valérie Petit; Franck Gesbert; Véronique Delmas; Hannah Seberg; Guillaume Meurice; Eric Van Otterloo; Philippe Dessen; Caroline Robert; Daniel Gautheret; Robert A Cornell; Alain Sarasin; Lionel Larue
Journal:  Cell Rep       Date:  2015-10-17       Impact factor: 9.423

8.  Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.

Authors:  Moshe Sade-Feldman; Keren Yizhak; Stacey L Bjorgaard; John P Ray; Carl G de Boer; Russell W Jenkins; David J Lieb; Jonathan H Chen; Dennie T Frederick; Michal Barzily-Rokni; Samuel S Freeman; Alexandre Reuben; Paul J Hoover; Alexandra-Chloé Villani; Elena Ivanova; Andrew Portell; Patrick H Lizotte; Amir R Aref; Jean-Pierre Eliane; Marc R Hammond; Hans Vitzthum; Shauna M Blackmon; Bo Li; Vancheswaran Gopalakrishnan; Sangeetha M Reddy; Zachary A Cooper; Cloud P Paweletz; David A Barbie; Anat Stemmer-Rachamimov; Keith T Flaherty; Jennifer A Wargo; Genevieve M Boland; Ryan J Sullivan; Gad Getz; Nir Hacohen
Journal:  Cell       Date:  2018-11-01       Impact factor: 41.582

9.  Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma.

Authors:  Jasper Wouters; Zeynep Kalender-Atak; Liesbeth Minnoye; Katina I Spanier; Maxime De Waegeneer; Carmen Bravo González-Blas; David Mauduit; Kristofer Davie; Gert Hulselmans; Ahmad Najem; Michael Dewaele; Dennis Pedri; Florian Rambow; Samira Makhzami; Valerie Christiaens; Frederik Ceyssens; Ghanem Ghanem; Jean-Christophe Marine; Suresh Poovathingal; Stein Aerts
Journal:  Nat Cell Biol       Date:  2020-08-03       Impact factor: 28.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.